Cardiometabolic Effects of Dipeptidyl Peptidase IV and Related

Recruiting

18 years - 99 years

All

Phase N/A

32 participants needed

1 Location

Brief description of study

DPP4 is an enzyme that breaks down proteins that may affect blood sugar and the heart. We will recruit individuals from the Penn Biobank (cases, controls). Participants will be asked to complete a meal test, DXA, and echocardiogram with exercise. A cardiac MRI and related pilot study are optional.

Eligibility of study

You may be eligible for this study if you meet the following criteria:

Conditions: heart,cardio,cardiology
Age: 18 years - 99 years
Gender: All

Updated on 04 Aug 2024. Study ID: 834482

Find a site

Your Information has been sent successfully.

We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.

Would you like to be notified about other trials? Sign up for Patient Notification Services.

Send a message

Enter your contact details to connect with study team

Primary Contact

First name*

Last name*

Email*

Phone number*

Preferred way of contact

Race

Ethnicity

Are you Healthy Volunteer

Are you comfortable with the informed consent process?

Yes

Other language

By sending a message, I agree that my data will be sent to a representative for the selected site and processed in accordance with this website's Privacy Policy (see link in footer).

Cardiometabolic Effects of Dipeptidyl Peptidase IV and Related Pathways

Brief description of study

Eligibility of study

Find a site

Interested in the study